HeartStart FRx Defibrillator
PHILIPS MEDICAL SYSTEMS · Decision date Feb 2, 2026
What did the FDA decide?
FDA records P180028/S018 as a supplement to PMA P180028, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Feb 2, 2026.
FDA approval order statement
an update from the current manual manufacturing method to a semi-automated manufacturing method
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Feb 2, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P180028/S018
- Regulatory pathway
- PMA supplement
- Applicant
- PHILIPS MEDICAL SYSTEMS
- Product code
- MKJ
- Decision code
- OK30
- Decision date
- Feb 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- PHILIPS MEDICAL SYSTEMS
- Product code
- MKJ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P180028/S017 · Related supplement
HeartStart FRx Defibrillator and HeartStart SMART Pads II
P180028/S018 received
Application receipt date recorded by FDA.
P180028/S018 · FDA decision
30-Day Notice
P180028/S019 · Related supplement
HeartStart FRx Defibrillator (861304)
Timeline entries are records held by MedtechLedger for P180028. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P180028
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| PHILIPS MEDICAL SYSTEMS | PMA supplement | Sep 5, 2025 | FDA | |
HeartStart FRx Defibrillator (861304)P180028/S019 | PHILIPS MEDICAL SYSTEMS | PMA supplement | May 21, 2026 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
PHILIPS MEDICAL SYSTEMS
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 22100 Bothell Everett Hwy., Bothell, WA, 98021
Sources and methodology
- Original FDA record: P180028/S018
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



